IP Library Granted Patent US 9,334,333
Granted Patent B2
US 9,334,333 · App. 14/800,257 · Granted May 10, 2016

Hybrid light chain mice

Inventors: Lynn Macdonald (White Plains, NY); Sean Stevens (San Diego, CA); Cagan Gurer (Valhalla, NY); Andrew J. Murphy (Croton-On-Hudson, NY); Karolina A. Meagher (Tarrytown, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
C07K16/462A01K67/0275A01K67/0278C07K16/00C07K16/18C07K16/461C12N15/10C12N15/8509A01K2207/15A01K2217/05A01K2217/052A01K2217/072A01K2217/15A01K2227/105A01K2267/01A01K2267/02A01K2267/0381C07K2317/10C07K2317/14C07K2317/21C07K2317/24C07K2317/50C07K2317/515C07K2317/56C07K2317/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,334,333
App. No.
14/800,257
Granted
May 10, 2016
Kind
B2
Abstract

Genetically modified mice are provided that express human λ variable (hVλ) sequences, including mice that express hVλ sequences from an endogenous mouse λ light chain locus, mice that express hVλ sequences from an endogenous mouse κ light chain locus, and mice that express hVλ sequences from a transgene or an episome wherein the hVλ sequence is linked to a mouse constant sequence. Mice are provided that are a source of somatically mutated human λ variable sequences useful for making antigen-binding proteins. Compositions and methods for making antigen-binding proteins that comprise human λ variable sequences, including human antibodies, are provided.

Claims (21)

1. A mouse comprising in its germline:

(a) an unrearranged light chain variable region comprising a plurality of contiguous unrearranged functional human λ light chain V (hVλ) gene segments and a plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments, wherein the plurality of hVλ gene segments and the plurality of hJλ gene segments are the only functional variable region gene segments in the unrearranged light chain variable region; and

(b) a mouse κ light chain constant region gene, wherein the plurality of contiguous unrearranged functional hVλ gene segments and the plurality of contiguous unrearranged functional hJλ gene segments are operably linked to the mouse κ light chain constant region gene such that the unrearranged light chain variable region is capable of rearranging to form a rearranged human λ light chain variable region and the mouse expresses antibodies comprising a light chain comprising a variable domain encoded by the rearranged human λ light chain variable region and a constant domain encoded by the mouse κ light chain constant region gene.

2. The mouse of claim 1 , wherein the plurality of hVλ gene segments are at least 12 hVλ gene segments.

3. The mouse of claim 1 , wherein the plurality of hJλ gene segments are selected from the group consisting of Jλ1, Jλ2, Jλ3, Jλ7, and a combination thereof.

4. The mouse of claim 1 , wherein an endogenous mouse λ light chain locus is deleted in whole or in part.

5. The mouse of claim 1 , wherein about 10% to about 45% of the B cells of the mouse express the antibodies comprising a light chain comprising a variable domain encoded by the rearranged human λ light chain variable region and a constant domain encoded by the mouse κ light chain constant region gene.

6. The mouse of claim 1 , wherein the unrearranged light chain variable region comprises a human Vκ-Jκ intergenic region from a human κ light chain locus located downstream of the most 3′ hVλ gene segment and upstream of the most 5′ hJλ gene segment.

7. The mouse of claim 1 , wherein the plurality of hJλ gene segments comprises 4 hJλ gene segments.

8. The mouse of claim 7 , wherein the 4 hJλ gene segments are Jλ1, Jλ2, Jλ3 and Jλ7.

9. A mouse comprising in its germline:

(a) an unrearranged light chain variable region comprising:

(i) at least 12 contiguous unrearranged functional human λ light chain V (hVλ) gene segments and a plurality of contiguous unrearranged functional human λ light chain J (hJλ) gene segments, wherein the at least 12 functional hVλ gene segments and the plurality of functional hJλ gene segments are the only functional variable region gene segments in the unrearranged light chain variable region; and

(ii) a human Vκ-Jκ intergenic sequence located between the contiguous hVλ gene segments and the plurality of contiguous hJλ gene segments; and

(b) a mouse κ light chain constant region gene;

wherein the at least 12 contiguous unrearranged functional hVλ gene segments and the plurality of contiguous unrearranged functional hJλ gene segments are operably linked to the mouse κ light chain constant region gene such that the unrearranged light chain variable region is capable of rearranging to form a rearranged human λ light chain variable region and the mouse expresses antibodies comprising a light chain comprising a variable domain encoded by the rearranged human λ light chain variable region and a constant domain encoded by the mouse κ light chain constant region gene.

10. The mouse of claim 9 , wherein the unrearranged light chain variable region comprises at least 28 unrearranged hVλ gene segments.

11. The mouse of claim 9 , wherein the unrearranged light chain variable region comprises at least 40 unrearranged hVλ gene segments.

12. The mouse of claim 9 , wherein the human Vκ-Jκ intergenic region comprises SEQ ID NO: 100.

13. The mouse of claim 9 , wherein the plurality of hJλ gene segments comprises 4 hJλ gene segments.

14. The mouse of claim 13 , wherein the 4 hJλ gene segments are Jλ1, Jλ2, Jλ3 and Jλ7.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2015
From: MACDONALD, LYNN; STEVENS, SEAN; GURER, CAGAN; MURPHY, ANDREW J.; MEAGHER, KAROLINA A
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 036286/0701 →
Continuity (5)
Continuation 14715147 · May 18, 2015
Continuation 13166200 · Jun 22, 2011
Provisional Application 61357314 · Jun 22, 2010
Provisional Application 61357317 · Jun 22, 2010
Related Publication 20150351371A1 · Dec 10, 2015